Have you been diagnosed with Gleason 3+4 prostate cancer?
Learn more about our unique ablation technology
MagForce® USA, Inc. is conducting a clinical study evaluating NanoTherm® in the ablation of prostate cancer.
What is NanoTherm® Therapy?
NanoTherm® is an investigational treatment that uses magnetic nanoparticles and an alternating magnetic field to create heat and local ablation of the cancer lesion.
About this study
After screening, treatment with NanoTherm® requires two appointments over a week. After completing the treatment, you will have follow-up visits at 1 week, 1 month, and 4 months. Find this study on clinicaltrials.gov using NCT05010759.
What are the benefits for me?
Alternative Therapy
If your therapy is a success, you may be able to return to Active Surveillance and not require immediate definitive treatment.
Compensation
Compensation of up to $3,500 if all long-term follow up visits are completed.
Travel Expenses
MagForce® USA will cover the costs of study related travel, meals and lodgings.
Participate in the Study
We are currently enrolling participants for our Stage 2-B Study to be conducted in the Spring of 2022.
To qualify you should:
• Be 40 to 85 years of age
• Have a diagnosis of prostate cancer from a biopsy (Gleason 3+4)
• Have no metallic implants below your shoulders
For more information, complete the contact form and we will contact you for an evaluation to confirm eligibility.
Contact MagForce® USA at (833) 287-1150 or email at prostatestudy@magforce-usa.com